Farther Finance Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Farther Finance Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Buy	21,332 +3,504	+20%	+$58K	﹤0.01%	1852
2026 Q1	$335K	Buy	17,828 +7,959	+81%	+$140K	﹤0.01%	1675
2025 Q4	$154K	Buy	9,869 +2,868	+41%	+$41K	﹤0.01%	2079
2025 Q3	$102K	Buy	7,001 +1,378	+25%	+$20.5K	﹤0.01%	2033
2025 Q2	$86.9K	Buy	5,623 +1,003	+22%	+$14.8K	﹤0.01%	1828
2025 Q1	$68.8K	Buy	4,620 +1,045	+29%	+$14.6K	﹤0.01%	1722
2024 Q4	$47.3K	Buy	3,575 +1,976	+124%	+$27.1K	﹤0.01%	1688
2024 Q3	$22.7K	Buy	1,599 +238	+17%	+$3.38K	﹤0.01%	2031
2024 Q2	$17.7K	Buy	1,361 +325	+31%	+$4.3K	﹤0.01%	1821
2024 Q1	$14.2K	Sell	1,036 -632	-38%	-$9.19K	﹤0.01%	1618
2023 Q4	$23.8K	Buy	1,668 +867	+108%	+$12.3K	﹤0.01%	1289
2023 Q3	$12.4K	Buy	801 +733	+1,078%	+$11.3K	﹤0.01%	1223
2023 Q2	$1.07K	Hold	68	–	–	﹤0.01%	1956
2023 Q1	$1.12K	Hold	68	–	–	﹤0.01%	1820
2022 Q4	$1.06K	Buy	+68	New	+$950	﹤0.01%	1636

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Farther Finance Advisors's TAK Position: Q2 2026 in Review

Farther Finance Advisors increased its Takeda Pharmaceutical (TAK) stake by 20% in Q2 2026, buying an estimated $58K and bringing the position to 21,332 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Farther Finance Advisors first reported a position in TAK in Q4 2022 and has held it in 15 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Farther Finance Advisors held 21,332 shares of Takeda Pharmaceutical worth $342K as of Q2 2026.
Farther Finance Advisors bought 3,504 Takeda Pharmaceutical shares in Q2 2026, an estimated $58K.
Takeda Pharmaceutical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1852 holding.
Farther Finance Advisors first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.